Deadline: 17-Feb-25
Pfizer is seeking proposals for its research grant to support prospective active surveillance studies on RSV-related Respiratory Tract Infection (RSV-RTI) in the pediatric population.
The initiative seeks to enhance the understanding of RSV-RTI and support evidence-based decision-making in managing and preventing these infections, with a focus on collecting pediatric data to gain a more comprehensive understanding and obtain more robust information on local pediatric data.
Area of Interest
- Potential applicants are encouraged to address existing evidence gaps through multi-center observational studies that focus on understanding the local disease incidence and clinical course of RSV-RTI in the pediatric population.
- This may include:
- Local Active Surveillance: Cover more than two sites in Taiwan, including outpatient, emergency, and inpatient settings.
- Study Population and Outcome Variables: Include details on the pediatric population from birth to < 18 years (especially during the first 12 months post-birth/pregnancy), risk factors for severe RSV disease, clinical outcomes, and costs associated with hospitalization.
- Concurrent Infections: Encouraged to include data on concurrent infections by bacterial and viral etiology of lower tract infections, in addition to data on viral respiratory tract infections confirmed as attributable to RSV.
- Priority will be given to proposals requiring updated local data not available from existing sources.
Funding Information
- Funding support is available up to 170,000 USD for at least 1 project anticipated to be completed within 12-18 months.
Eligibility Criteria
- Geographic Scope/Location of Project/Study: Taiwan
- The institution and Principal Investigator (PI) must be based in one of the eligible countries noted above.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
- The PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Limited. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Limited may be subject to rescission.
For more information, visit Pfizer.